Skip Page Header

Home > Manual: increasing access to hepatitis C testing and care for people who inject drugs. Identifying barriers to and opportunities for supporting hepatitis C testing and care in drug services: a participatory diagnostic process.

European Monitoring Centre for Drugs and Drug Addiction. (2021) Manual: increasing access to hepatitis C testing and care for people who inject drugs. Identifying barriers to and opportunities for supporting hepatitis C testing and care in drug services: a participatory diagnostic process. Luxembourg: Publications Office of the European Union. DOI 10.2810/033126.

[img]
Preview
PDF (Manual: increasing access to hepatitis C testing and care for people who inject drugs)
461kB
[img]
Preview
PDF (EMCDDA guide to holding a stakeholder round-table on supporting hepatitis C testing and care in drug services)
659kB

This manual provides a step-by-step guide for those involved in planning and managing infectious diseases and drug services, focusing on how to identify barriers to and opportunities for improving provision of HCV testing and access to treatment for people who use drugs. In particular, it focuses on HCV testing in harm reduction and drug treatment settings.

The second guide is aimed at supporting teams organising stakeholder round-table meetings as part of their regional or national diagnostic processes aimed at identifying barriers to and opportunities to increase hepatitis C virus testing and care in drug services.

This manual provides a step-by-step guide for those involved in planning and managing infectious diseases and drug services, focusing on how to identify barriers to and opportunities for improving provision of HCV testing and access to treatment for people who use drugs. In particular, it focuses on HCV testing in harm reduction and drug treatment settings.

The second guide is aimed at supporting teams organising stakeholder round-table meetings as part of their regional or national diagnostic processes aimed at identifying barriers to and opportunities to increase hepatitis C virus testing and care in drug services.

See also, from the EMCDDA: 

Repository Staff Only: item control page